Ranbaxy Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 14	Jun ' 13	Dec ' 12	Jun ' 12	Dec ' 11

Sales

3,487.31

2,820.52

2,911.17

3,392.37

5,312.78

Operating profit

770.72

-118.90

143.59

316.90

986.52

Interest

278.74

206.73

116.91

180.07

283.92

Gross profit

537.76

-242.27

151.50

251.61

926.39

EPS (Rs)

9.13

-12.73

-1.51

-2.33

-74.63

Other income

45.78

83.37

124.82

114.78

223.79

Stock adjustment

203.91

-25.06

-41.94

-7.31

17.41

Raw material

616.67

810.22

785.61

751.16

902.62

Power and fuel

-

-

-

-

-

Employee expenses

534.41

508.88

514.79

504.80

410.65

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1,361.61

1,645.39

1,509.12

1,826.83

2,995.58

Provisions made

-

-

-

-

-

Depreciation

125.80

89.94

90.75

95.41

180.84

Taxation

9.24

-

-1.94

-

9.00

Net profit / loss

386.87

-538.66

-63.90

-98.44

-3,149.52

Extra ordinary item

-15.86

-206.46

-126.59

-254.64

-3,886.06

Prior year adjustments

-

-

-

-

-

Equity capital

211.95

211.55

211.46

211.06

211.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

1493.14

1456.79

1452.39

1450.06

1458.28

Agg.of non promotoholding (%)

35.22

34.43

34.34

34.35

34.56

OPM (%)

22.10

-4.22

4.93

9.34

18.57

GPM (%)

15.22

-8.34

4.99

7.17

16.73

NPM (%)

10.95

-18.55

-2.10

-2.81

-56.89